Product Description
BTL EMSELLA uses HIFEM technology for PFM strengthening and reduction of UI. The device is consisted of a power generator and a circular coil mounted in the seat of the chair. (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016513/)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Colombia
Approved Indications: None
Known Adverse Events: None
Company: William Beaumont Hospitals
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| NCT04133675 | N/A |
Recruiting |
Urinary Incontinence, Stress|Enuresis |
2027-10-01 |
|
| Emsella_EJD | N/A |
Recruiting |
Aging, Premature|Liver Failure|Pelvic Pain|Premature Ejaculation|Erectile Dysfunction |
2026-07-01 |
|
| EmsellaOAB | N/A |
Recruiting |
Overactive Bladder |
2026-06-01 |
|
| NCT04031014 | N/A |
Recruiting |
Overactive Bladder|Urinary Incontinence, Urge|Urinary Incontinence, Stress|Enuresis |
2025-07-01 |